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The ability to predict if a given mutation is disease-causing or not has enormous potential to
impact human health. Typically, these predictions are made by assessing the effects of mutation on
macromolecular stability and amino acid conservation. Here we report a novel feature: the electrostatic
component of the force acting between a kinesin motor domain and tubulin. We demonstrate that
changes in the electrostatic component of the binding force are able to discriminate between diseasecausing and non-disease-causing mutations found in human kinesin motor domains using the receiver
operating characteristic (ROC). Because diseases may originate from multiple effects not related to
kinesin-microtubule binding, the prediction rate of 0.843 area under the ROC plot due to the change
in magnitude of the electrostatic force alone is remarkable. These results reflect the dependence of
kinesin’s function on motility along the microtubule, which suggests a precise balance of microtubule
binding forces is required.
The ability to predict if genetic mutations cause disease or not has enormous potential to impact human health1, 2.
Efforts to make these predictions to date have largely been done by assessing the effect of a genetic mutation on
the coded protein’s stability and amino acid conservation3, 4. While these predictions have had some success based
on genome-wide work5, when considering the disease-causing effects of mutations in particular protein families,
other, more function specific, features may be more successful6, 7.
The kinesin superfamily of microtubule motor proteins is responsible for a diverse set of cell biological functions including intracellular transport, ciliary assembly, mitosis, meiosis, cytoskeletal morphology, and microtubule dynamics regulation8, 9. These functions depend on kinesin’s force generating and motile properties10, 11.
Kinesins, for example, are particularly critical to the development of neurons due to their ability to transport
intracellular cargos, including synaptic vesicles, mitochondria, and newly synthesized protein complexes from
the endoplasmic reticulum near the nucleus in the cell body to the growing tips of axons and dendrites12. Kinesins
enable elongated neurons, sometimes more than a meter long, to overcome physical limitations associated with
long distance diffusion13.
To accomplish the diversity of functions that kinesins perform, there are 14 recognized and numbered families
of kinesins8, 14, as well as numerous ungrouped, or orphan, kinesins8. Most members of the kinesin superfamily
are microtubule plus end-directed motors12. Some notable exceptions include kinesin-13s, which are primarily
involved in regulation of microtubule dynamics15 and move by diffusion16, and kinesin-14s, which are minus
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end-directed motors17, 18. Kinesin motor motility and pN-scale forces arise from structural changes in the neck
linker subdomains19, 20 of kinesins upon hydrolysis of ATP21. However, these forces are not the only forces within
kinesins that are critical to their function.
The forces of binding between a kinesin and the microtubule are additionally important to the motor’s processivity, which is a motility property determined by how far it moves along a microtubule before completely
dissociating13. A single bound kinesin motor domain is in a state of force equilibrium in the absence of external
loading, meaning that the sum of all forces between the microtubule and the kinesin must be zero. These forces
are electrostatic and non-electrostatic forces, including hydrogen bonds and salt bridges, van der Waals forces,
as well as others. However, because the charge of amino acids at the microtubule binding interface greatly affects
the motility and microtubule-stimulated ATPase rate of kinesin22, the dominant force associated with binding is
likely the electrostatic force. Electrostatic forces guide kinesin-1 to its binding site23 and allow it to follow a single
protofilament24, 25. Electrostatic forces also likely underlie the diffusive motility of kinesin-826, 27 and kinesin-1316.
Kinesins are critical to cell biology, so they are also important to many aspects of life, particularly to cell
division and the nervous system. Genetic defects in kinesin motor domains that cause errors in cell division are
likely embryonic lethal. Somatic defects are found in and are distributed throughout many kinesins, including
the motor domains28. These defects are prevalent in endometrial cancer, lung squamous cell carcinoma, and
melanoma28. However, somatic defects are generally unique to single samples making it difficult to discern
their significance to the cancer28. Multiple congenital disorders are caused by non-synonymous single nucleotide polymorphisms (nsSNPs) in kinesin motor domains, including nsSNPs in the kinesin-1 family member
KIF5A that cause parkinsonism29, peripheral neuropathy29–32, Charcot–Marie–Tooth disease type 233, retinitis pigmentosa29, and spastic paraplegia33–35; nsSNPs in the kinesin-1 family member KIF5C and the kinesin-5
family member KIF11 that cause microcephaly36, 37; nsSNPs in the kinesin-10 family member KIF22 that cause
lepto-spondyloepimetaphyseal dysplasia38; nsSNPs in the kinesin-3 family member KIF1A that cause spastic
paraparesis and sensory and autonomic neuropathy type-239; and nsSNPs in the kinesin-5 family member KIF11
that cause primary lymphedema and chorioretinal dysplasia37.
Because nsSNPs in kinesins tend to cause neurological genetic disorders and electrostatic forces between
the kinesin motor domain and the microtubule are critical to multiple physiological properties of kinesins that
could be particularly important in neurons, we hypothesized that the nsSNPs found in kinesin motor domains
that greatly affect the electrostatic forces acting between kinesin and microtubules would strongly correlate to
the nsSNPs causing human disease. To probe this hypothesis, we investigated the effect of known kinesin motor
domain nsSNPs on the electrostatic force between kinesin and tubulin dimers using computational techniques.
This study is based on 50 nsSNPs causing missense mutations in the motor domains of 10 different genes coding
for proteins from 8 different kinesin families identified from dbNSFP40 and annotated as disease-causing using
the Human Gene Mutation Database41 and ClinVar42 complemented with 11 nsSNPs that do not cause disease
taken from 1000 genomes project43. The goal is to determine whether the changes in the electrostatic forces
caused by mutations can be used to discriminate disease-causing mutations from those that do not cause human
disease.

Materials and Methods

Selection of kinesin nsSNPs. The kinesin nsSNPs were downloaded from dbNSFP40 and missense mutations located in the coding regions of the kinesin motors domains with structures available in the PDB44 were
selected. The Human Gene Mutation Database (HGMD)41 and ClinVar42 were used to identify disease-causing
mutations. This resulted in the selection of 50 mutations in various kinesins.
A total of 11 nsSNPs with the allele frequency greater than 1% in the 1000 Genomes Project45 were identified
and used as common, non-disease causing polymorphisms in the healthy individuals.
Note that significantly more disease-causing mutations were identified than non-disease-causing mutations,
but the inclusion of mutations with allele frequency smaller than 1% may result in mutations with unknown physiological importance. The list of all the mutations for this study is provided in Supplementary Materials Table S1.
Preparation of kinesin-tubulin structures. The 61 selected mutants come from 10 kinesin proteins rep-

resenting 8 kinesin families (Table 1). High resolution structures, those with better than 5 Å resolution and having
no mutation, were downloaded from the Protein Data Bank (PDB)46 for 5 of the 10 kinesin proteins. If multiple
structures were available for the same kinesin in PDB, the structure with the highest resolution was selected for
this work.
High resolution structures were not available in the PDB for the other 5 kinesin proteins. Note that for some
proteins, including KIF1A and KIF5A, structures were available, however, either the resolution was too low or the
structure had mutations introduced into it. In the cases without structure, SWISS-MODEL47 was used to build
protein homology models from templates with high sequence similarities. The top model from SWISS-MODEL
was selected to model the corresponding kinesin motor structures.
Some of the structures had missing heavy atoms. Profix48 was used to fix these structures.
NAMD49 was used to perform a 10,000-step energy minimization for each structure. In NAMD minimizations, the CHARMM50 force field and the Generalized Born (GB) implicit solvent model were used.
There were no structures of the human kinesin-human tubulin complex available in PDB. However, there were
many other kinesin-tubulin complex structures available, and kinesins share the same microtubule binding site22, 51.
Therefore, kinesin-tubulin complex structures were made using Chimera52 to align each kinesin (Table 1) to the
human α1A/β3 tubulin dimer structure (PDB ID 5JCO)53, using a model of human kinesin-5 and a mammalian
tubulin dimer docked into a 9.5- Å cryo-EM map (PDB ID 4AQW)54 as a template. The C-termini (E-hooks) were
not modeled since their structures are not available in the corresponding PDB files.
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Kinesin
family

Human
protein name PDB:

Kinesin-1

KIF5A

Swiss model 3WRD.A – mouse kinesin 1 (KIF5C) apo

91.2

2.9

71

KIF5C

5HNY.C – rat kinesin 1/Drosophila
Swiss model
kinesin 14 chimera (KIF5C/NCD)

97.8

6.3

72

Kinesin-1

Nucleotide
Sequence
state of motor Similarity (%)

Template

AMPPNP

X-ray
resolution (Å) Ref.

Kinesin-3

KIF1A

Swiss model 2HXH.C – mouse kinesin 3 (KIF1A)

ADP

95.9

11

73

Kinesin-4

KIF21A

Swiss model 3ZFD.A – mouse kinesin 4 (KIF4)

AMPPNP

57.1

1.7

74

52.5

Kinesin-4

KIF27

Swiss model 3ZFD.A - mouse kinesin 4 (KIF4)

AMPPNP

Kinesin-5

KIF11

1II6.A

ADP

1.7

74

2.1

75

Kinesin-8

KIF18A

3LRE.A

ADP

2.2

68

Kinesin-9

KIF9

3NWN.A

ADP

2.0

44

Kinesin-10

KIF22

3BFN.A

ADP

2.3

44

Kinesin-13

KIF2C

2HEH.A

ADP

2.2

44

Table 1. Details of the 10 wild type kinesin structures used.

Building complex structure via structural alignment of the backbone atoms resulted in atomic clashes
at the binding interface. To remove these structural clashes introduced during the modeling process, the
kinesin-tubulin complex structures underwent 2000 steps of energy minimization using the CHARMM3655 force
field in CHARMM56 software in which only amino acid side chains were free to move because a 10 kcal·mol−1·Å−1
harmonic constraint was placed on all backbone atoms.
The nsSNP structures were generated based on the wild type structure for each kinesin using PDB2PQR57. The
protonation states of titratable group were assumed to be standard, roughly corresponding to pH = 7.0. Since the
kinesins considered in this work are cytoplasmic kinesins, the physiological pH is 7.0. Only the mutated residue
was energy optimized; all other atoms were kept in the same position as in the wild type structure to isolate the
direct effects of electrostatic forces.

Force calculations. Electrostatic forces were calculated for each kinesin-tubulin complex using
DelPhiForce58. The force reported is the net electrostatic force exerted on a kinesin by its tubulin dimer binding
partner. The electrostatic force on each individual atom and residue, which is used to analyze the detailed force
distribution on each kinesin, was also calculated with DelPhiForce.
The forces on each kinesin were calculated in two states: the bound state and the unbound state. The bound
state was considered to be the equilibrium complex position, which was determined as described in “Preparation
of kinesin-tubulin structures”. The unbound state was obtained by displacing the kinesin 5 Å from the tubulin in
the direction along the line between the mass center of the kinesin and tubulin dimer. The dielectric constant for
water and protein were set as 80 and 2, respectively; the resolution of the grid was set at 2 grids/Å; the perfil was
set at 70; the ionic strength of the solvent was set at 0 (zero salt concentration was used to be consistent with our
previous studies and to avoid the ambiguity associated with explicit ion binding). However, to check the sensitivity of results, parallel calculations were done at physiological salt concentration corresponding to ionic strength
I = 0.15 M. The dipolar boundary condition was used in all cases. Information on these parameters is available in
the DelPhi59, 60 manual (http://compbio.clemson.edu/downloadDir/delphi/delphi_manual.pdf).
The electrostatic force difference, ∆F , was defined as the difference between the electrostatic forces exerted on
wild type and the corresponding mutant kinesins.
∆F = Fmut − Fwt

(1)

where ∆F and are vector quantities with components ΔFlat (lateral direction), ΔFlong (longitude direction), and
ΔFbind (binding direction).
The relative force difference ΔFrel is defined as:
∆Frel = Fmut − Fwt / Fwt

(2)

The relative force difference in the binding direction ΔFbind,rel is defined as
∆Fbind,rel = |F¯bind,mut − F¯bind,wt| /|F¯bind,wt|

(3)

where Fbind,mut and Fbind,wt are the components of the electrostatic force between the microtubule and the mutant
and wild type kinesin in the binding direction, respectively.

Results

Electrostatic forces act between kinesin and tubulin. In our previous work, we demonstrated that
the electrostatic forces on kinesin-5 form a binding funnel around the tubulin dimer58. A similar binding funnel
was also found for dynein around the tubulin binding pocket61. In this work, we found that the binding funnel
is common to kinesins, as shown for kinesin-13 as an example (Fig. 1), and that the electrostatic force guides the
kinesin to the binding pocket of the tubulin. We obtained similar results for the other kinesins (Supplementary
Material Table S1).
SCientifiC REPorTs | 7: 8237 | DOI:10.1038/s41598-017-08419-7
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Figure 1. A funnel of electrostatic binding forces guides kinesin to the binding site on a tubulin dimer. The
kinesin-13 structure (yellow) was shifted 20 Å away from its bound position and circled around the tubulin
dimer (colored blue for positive surface charge and red for negative surface charge) along a circle with a radius
of 40 Å. Every 30 degrees, the electrostatic force on the kinesin was calculated. These forces are represented by
arrows (green) with their tail end located at the mass center of the kinesin in the 12 locations around the circle
and their lengths proportional to the magnitude of the electrostatic force. (A) and (C) are the side views. (B) and
(D) are the top views. In (A) and (B) the kinesin structure is shown at two positions for illustration of the range
of displacement. In (C) and (D) the kinesin is hidden to provide clear view of the forces. In all frames, the total
electrostatic forces were calculated using DelPhiForce and visualized with VMD76.
Because the electrostatic force is a vector, F , we examined its components in the longitudinal (Flong), lateral
(Flat), and binding (Fbind) directions (Fig. 2) separately to further assess the role of electrostatic forces. We found
that the magnitude of the mean electrostatic force, |Favg|, for the 10 wild type kinesins used in this study in the
bound state was 1,450 ± 170 pN (results for each kinesin are shown in Supplemental Material Table S1).
Preforming the same calculations for unbound kinesins (at a displacement of 5 Å from the tubulin) resulted in an
87% decrease in |Favg| to 192 ± 56 pN. However, despite the large drop in magnitude, the direction of that mean
force, and therefore the contribution of individual components, in the bound state was statistically indistinguishable from the unbound state (Table 2). The component of the mean electrostatic force in the binding direction,
Fbind,avg, contributed the most to the force magnitude (Table 2), and the components in the lateral, Flat,avg, and
longitudinal, Flong,avg, directions were not statistically different from zero (Table 2).

Electrostatic forces and diseases.

We calculated the electrostatic force differences, ∆F (Equation 1), of
bound and unbound structures (Supplementary Material Table S1), where the force difference quantifies the difference in electrostatic force between the mutant and the corresponding wild type structure. Like the electrostatic
force, force differences have three components in the longitudinal (ΔFlong), lateral (ΔFlat), and binding (ΔFbind)
directions (Fig. 2). Besides the force differences, we also calculated the relative force difference ΔFrel (Equation 2).
We found that mutations with larger values of relative force differences, ΔFrel, are more likely to cause disease
(Supplementary Material Table S1).
We quantified the result that large ΔFrel tends to cause disease using Receiver Operating Characteristic
(ROC) plots (Fig. 3). The area under an ROC plot indicates how well a descriptor, in this case ΔFrel, discriminates
between two states, in this case whether a mutation is disease-causing or non-disease-causing. The area under an
ROC plot of 1 indicates the descriptor can always discriminate between the states, and the area under a ROC plot
of 0.5 (corresponding to the red dotted line in Fig. 3) indicates the descriptor is no better than random chance.
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Figure 2. Definition of forces components. As an illustrative example, kinesin-3 family member KIF1A (light
blue) is shown in the bound state on a tubulin dimer with α-tubulin (red) on the left side and β-tubulin (orange)
on the right side. The “longitudinal” direction is along the microtubule, shown (green arrow) positive pointing
toward the plus end. The “binding” direction is normal to the surface of the microtubule, shown (green arrow)
positive toward the microtubule lumen. The “lateral” direction is around the microtubule, shown (green
indicator) coming out of the page toward the reader.

Kinesin/Tubulin
State

Electrostatic
force magnitude
(pN)

Components of the unit vector
Lateral

Binding

Longitudinal

Bound state

1450 ± 170

−0.16 ± 0.17

0.67 ± 0.08

0.10 ± 0.15

Unbound state

192 ± 56

−0.15 ± 0.17

0.77 ± 0.07

−0.01 ± 0.09

Table 2. Mean electrostatic force magnitude and direction. Note: Values are reported as mean ± standard error
of the mean; n = 10 wild type kinesin proteins.

We found that ΔFrel of unbound structures provided a better prediction of disease than ΔFrel of bound structures because the areas under the unbound state ROC plots were 0.84 and 0.84 for ΔFrel and ΔFbind,rel, respectively
(Fig. 3) and the area under the bound state ROC plots were 0.79 and 0.77 for ΔFrel and ΔFbind,rel, respectively
(Fig. 3). We also noted that ΔFrel performed slightly better than ΔFbind,rel for structures in bound states (Fig. 3).
We obtained similar results from ROC plots (Supplementary Material Figure S1) of electrostatic force calculations
at an ionic strength of 0.15 M, indicating that ionic strength does not play a role in discriminating disease-causing
from non-disease-causing mutations. Thus, in the rest of the manuscript, we focus on results obtained with I = 0
M. Since disease can be caused by either decreasing or increasing the wild type force, we did ROC using the absolute values of ∆F and |ΔFbind|, for both unbound and bound states, which resulted in similar as above performance; areas under ROC curve ranged from 0.72 to 0.75 (Supplementary Material Figure S2).

Statistical analysis of electrostatic force components and disease-causing mutations. We further investigated the unbound state’s ∆F and its ∆F ’s components as predictors of whether a mutation is
disease-causing or non-disease-causing using histograms (Fig. 4). We found that all mutations in our study with
∆F > 16 pN led to disease and that only 9% of the non-disease causing mutations had ∆F > 4 pN (Fig. 4A).
We also found that kinesins had a higher tolerance to ΔFbind and ΔFlong than to ΔFlat. We found that
only 9% of the non-disease-causing mutants had ΔFlat > 1 pN while 36% had ΔFbind > 1 pN and 27% had
ΔFlong > 1 pN (Fig. 4B,C,D). We also noted that mutations causing ΔFlat between 1 pN and 4 pN did a much
better job distinguishing disease state because this range in ΔFlat contains 35% of all disease-causing but only 9%
of non-disease-causing mutants, which is statistically significantly different (p-value = 0.02), but this same range
in ΔFbind and ΔFlong had percentages of disease-causing and non-disease-causing that were statistically indistinguishable (Fig. 4B,C,D).
Analysis of additional features that may be used to discriminate disease-causing and
non-disease-causing mutations. We performed a statistical analysis of 23 features potentially affecting

the pathogenicity of kinesin mutations using standard techniques (see Supplementary Material). By comparing
the p-values of an F-regression analysis, we found that electrostatic force was the best predictor (Table 3). The
other good predictors were the secondary structure of mutation position, change in binding free energy, and the
location of mutation site (Table 3). The buried surface area, residue polarity, residue charge, etc., were not identified as significant features in predicting pathogenicity (Table 3).
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Figure 3. Magnitude of the electrostatic force difference, ΔFrel, can be used to predict whether a mutation is
disease-causing. ROC plots are of ΔFrel calculated in the bound state (BS Mag, black line), the component of
force difference in the binding direction, ΔFbind,rel, in the bound state (BS BC, blue line), ΔFrel in the unbound
(UBS Mag, red line), and ΔFbind,rel in the unbound state (UBS BC, green line). The areas below these four ROC
curves are: 0.79, 0.77, 0.84, 0.84, respectively.

Figure 4. Whether a mutation causes a disease or not is correlated to the electrostatic force differences.
Normalized histograms of disease-causing (black) and non-disease-causing (gray) mutations by electrostatic
force difference when kinesin is in the unbound state for (A) ∆F , (B) ΔFbind, (C) ΔFlat, and (D) ΔFlong. Total
mutation counts are labeled on each bar. Note that our dataset included a total of 50 disease-causing mutants
and 11 non-disease-causing mutants. The error bars indicate the standard deviation.

We found that 88% of the disease-causing mutations occur in α-helices, coils, and turns (Fig. 5A). Only 31% of
mutations located on strands caused disease, which is significantly fewer than the 61% and 53% disease-causing
rates for mutations on coils and turns, respectively (Fig. 5A). Our data had few instances of mutations on 3–10
helices or salt bridges, therefore these mutations are not taken into further analysis.
Additionally, we noted that the disease-causing nature of a mutation was correlated to the function of the
structure domain upon which it resides. 76% of mutations at the tubulin binding site were disease-causing
(Fig. 5B), while mutations at other locations were disease-causing in only 46% of instances (Fig. 5B). Note that
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Numerical Features

p-value in f
Regression

f Regression
Score

Difference in total force at 5 Å distance

0.02

5.33

Absolute difference in binding force at 5 Å distance

0.03

5.19

Absolute difference in longitudinal force at 5 Å distance 0.06

3.68

Absolute difference in lateral force at 5 Å distance

0.07

3.40

Change in charge

0.12

2.51

Change in binding free energy

0.13

2.38

Change in buried surface area

0.23

1.49

Absolute difference in longitudinal force at bound state

0.24

1.42

Difference in total force at bound state

0.25

1.34

Absolute difference in longitudinal force at bound state

0.25

1.34

Absolute difference in binding force at bound state

0.28

1.18

Absolute difference in lateral force at bound state

0.30

1.09

Difference in longitudinal force at bound state

0.35

0.90

Difference in binding force at bound state

0.39

0.74

Change in folding free energy

0.40

0.71

Difference in lateral force at bound state

0.47

0.53

Difference in binding force at 5 Å Distance

0.57

0.33

Difference in lateral force at 5 Å Distance

0.60

0.28

Difference in longitudinal force at 5 Å Distance

0.69

0.16

Categorical Features

Logistic Regression
Coefficient

Change in polarity

0.46

Residue on binding site

−0.01

Residue exposure

−0.08

Secondary structure of mutation residue

−0.23

Table 3. Statistical analysis of 23 possible features.

since this study focused on the kinesin-tubulin interaction, mutations on ATP binding site were not taken into
further discussion.

Discussion

We demonstrated that the changes of the electrostatic component of the force between kinesin and microtubule caused by amino acid mutations in the kinesin motor domain serve as a good discriminator between
disease-causing and non-disease-causing mutations. 23 other features typically used by the computational community were also investigated, but we found them to be not as good predictors of disease state as the change of
the electrostatic force. These results are remarkable because kinesin-related diseases may originate from nsSNPs
causing effects within the motor domain not related to kinesin-microtubule binding. These effects may include
disruption of nucleotide hydrolysis site because motility requires ATP hydrolysis62, proximity of the mutation to
the location neck-linker-motor domain interaction site because motility requires neck linker docking63, 64, and
motor domain structural stability because structure and function are closely correlated in structured proteins.
Additionally, the kinesin family to which the mutated protein belongs could also be an important factor because
certain families may have more critical cell or developmental biological function than others, and certain families may have fewer functional redundancies with other motors within the family than others65. Moreover, that
our results show electrostatic force is a good discriminator between disease-causing and non-disease causing
mutations suggests that there is steep electrostatic potential energy well about the kinesin docking location on
the microtubule. Because the force is proportional to the spatial gradient of potential energy, small changes in the
electrostatic energy potential result in large change in the force. Therefore, it is likely that electrostatic force is an
even better discriminator than electrostatic energy potential.
We checked if our results were biased by the location of the mutations sites relative to the kinesin-microtubule
binding interface by generating a representative kinesin motor domain-tubulin structure (Fig. 6). We note that
the kinesin motor domains studied in this work have similar structures (Fig. 6A), and thus we use one (kinesin-3)
to visualize the location of mutations sites (Fig. 6B). We found that there is no preference for disease-causing
mutations to be at the binding interface while non-disease-causing mutations are away.
Recent studies indicate that positively charged residues on the kinesin motor domain strengthens its interaction with the microtubule, while negatively charged residues have an opposite effect22, 23, 25, 66. Consistent with
these previous studies, we have found that most of the disease-causing mutations we studied involve charged
residues. Our findings provide additional evidence for the importance of charged residues and electrostatics to
kinesin motor domain microtubule binding. Furthermore, we found that Y274 and L248, which were previously
identified as the top two most important uncharged residues for kinesin-microtubule binding22, 66, were also
associated with disease-causing mutations in kinesin-3 family member KIF1A (L249Q) and in kinesin-1 family
SCientifiC REPorTs | 7: 8237 | DOI:10.1038/s41598-017-08419-7
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Figure 5. Location of the mutation is correlated to its likelihood of causing disease. (A) Histograms indicating
which secondary structure the mutated residue is on for disease-causing and non-disease-causing mutants. (B)
Histograms indicating whether the mutated residue is on the microtubule binding interface or not for diseasecausing and non-disease-causing mutants.

member KIF5A (Y276C). The correspondence between important previously identified charged and uncharged
residues22, 66 and disease-association allows us to speculate that mutations at other positions identified as important in previous studies22, 66 including R346, K44, and K261, which do not appear in our database, are likely to be
disease-causing.
Our key result is that if a mutation causes a ∆F > 4 pN in the unbound state, then it is very likely to cause
disease. Such a threshold roughly corresponds to 1 kcal/mol binding energy, an energy threshold that is widely
used to discriminate disease-causing from non-disease-causing mutations67. Below we investigate a few particular
mutants more closely, as illustrative examples, to understand our result a bit better.
First, we noted that kinesin-3 family member KIF1A E253K is charge reversal, from a negatively charged
glutamic acid residue to a positively charged lysine residue, and it resulted in the largest ∆F (Supplementary
Material Table S1) in both the bound and unbound states. We looked carefully at the magnitude and direction of
the force on each amino acid in this kinesin-3 (Fig. 7). We found that the mutated amino acid lies close to the
tubulin interface: the distance between the CA atom of E253 and the closest CA atom on tubulin is 9.6 Å. Because
the mutation flips the charge of the residue and it is so close to the highly-charged tubulin interface, the large
change in force we calculated was likely do the negative-to-positive charge reversal. The negatively charged E253
in wild type kinesin-3 opposes binding (Fig. 7 red arrow), and the positively charged K253 in the mutant
kinesin-3 favors binding (Fig. 7 blue arrow), to the net negatively charged tubulin dimer. It is therefore not surprising that the enhanced binding due to this mutation causes spastic paraparesis and sensory and autonomic
neuropathy type-239 given that kinesin-3 drives long-distance transport in neuronal cells9.
Second, we noted that kinesin-8 family member KIF18A T273A mutant is the only non-disease causing
mutant with a ∆F > 4 pN; it had ∆F = 4.92 pN. We looked carefully at the location of this residue in the
structure and found it to reside on an unstructured region (or at least one that is not in the PDB ID 3LRE structure)68 on the microtubule binding surface22, thus leading to a relatively large calculated ∆F . However, the T273
is not highly conserved and the T273A does not change the motility of the kinesin in in vitro motility assays22.
This could explain how this mutation is non-disease-causing despite relatively large ∆F .
Third, we noted that the kinesin-1 family member KIF5A S203C mutant has a low ∆F = 1.27 pN in the
unbound state (Supplementary Material Table S1), well below the discrimination threshold of 4 pN, but is
disease-causing. We looked carefully at the location of this mutation, and found it is located in close proximity
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Figure 6. Mutations distribution map. (A) The structural alignment for all the kinesin-tubulin dimer structures
studied, each color representing a different kinesin structure. (B) Mutations sites mapped on a representative
kinesin structure (kinesin-3 family member, KIF1A). Red residues indicate disease-causing mutation sites
and yellow residues indicate non-disease-causing mutation sites. α-tubulin (red) is on the left and β-tubulin
(orange) is on the right in both panels.

Figure 7. Forces on each residue of kinesin-3 show the large change in relative force due to the mutation.
Kinesin-3 family member KIF1A (light blue) with the E253K mutation is shown bound to a tubulin dimer
with α-tubulin (red) on the left side and β-tubulin (orange) on the right side. Most electrostatic forces (yellow
arrows) on each residue of the kinesin-3 remain unchanged, but the force on residue 253 changes with the
mutation, with both the force on wild type (red arrow) and the force on the mutant (blue arrow) shown.

(5.5 Å) to the Mg2+ ion in the nucleotide binding site69. Specifically, S203 resides within a highly conserved
sequence (NXXSSR, residues 199–204 of KIF5A) in switch I30, and it is thought to be important in recognizing
the hydrolysis state of bound the nucleotide70. This could explain how this mutation causes a disease despite low
∆F , highlighting our discrimination method’s limitation in finding all the true positive cases, particularly when
mutations are unrelated to the kinesin-tubulin interaction.
While we did find that ∆F > 4 pN in the unbound state is an excellent discriminator, we also found that
the three components of the relative force difference, ΔFlong,rel, ΔFlat,rel, and ΔFbind,rel, are also successful predictors, in their own right. These results suggest that the individual components of the binding force, particularly the
lateral and longitudinal components, may be of critical importance for kinesin motility. It should be additionally
noted that the magnitude of the electrostatic force is significantly (least 5-fold) larger in the binding direction
SCientifiC REPorTs | 7: 8237 | DOI:10.1038/s41598-017-08419-7
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than the other two directions (Table 1). Thus, it is likely to be less sensitive to the changes in magnitude than the
other directions. If a mutation changes the force in the binding direction a given amount, kinesin may still bind
to tubulin properly, however if the force in the lateral or longitudinal direction were changed by that same
amount, it may be significantly more sensitive to the difference. It should be noted that the absolute value of the
electrostatic force change was found to be the best discriminator. Thus, mutations strengthening the binding are
equally likely to be disease-causing as mutations weakening it. This is consistent with previous studies on other
systems, indicating that these systems are optimized and any deviation away from the wild type properties could
be disease-causing4, 67.
Finally, it should be noted that this study considers the electrostatic component of the force acting between
the kinesin and tubulin, not the total force. A kinesin motor domain that is not subjected to other external force,
e.g. a cargo load, is at equilibrium on the microtubule. Therefore, at equilibrium, non-electrostatic forces must be
acting at the tubulin-kinesin interface to balance out the large magnitude electrostatic forces we have calculated.
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